Table of Contents
Description
Priority Announcements on Fellowship competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the "200910MFE" competition of the Fellowship: 2009-2010 funding opportunity.
Fellowships provide support for highly qualified candidates at the post-PhD or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
Funds Available for Research in All Areas:
Funds are available for applications in all areas of research that address any important health problem or issue through the "200910MFE" competition of the Fellowship: 2009-2010 funding opportunity.
Funds Available for Research in Specific Areas:
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
A. CIHR Research Priority Areas
B. Prizes in CIHR Research Priority Areas
Top
Objectives
The specific objective of the Fellowship Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.
A. CIHR Research Priority Areas
1. Aging - Longitudinal Studies
Summary
- CIHR, under the Canadian Longitudinal Study on Aging (CLSA) initiative, will fund applications that are determined to be relevant to the research priority areas described below:
- Development, design, planning, data collection and/or analysis of health measurement studies with emphasis on the CLSA and similar longitudinal studies.
- More information on the objectives and relevant research areas is available on the Canadian Longitudinal Study on Aging Fellowships webpage.
- CIHR-IA will evaluate applications for relevance to the research priorities which must be addressed within one relevance form (see "How to Apply").
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 3 years. The total amount available for this initiative is $360,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- Candidates are encouraged to consider a supervisor who is a researcher linked to the Canadian Longitudinal Study on Aging, such as the CLSA Principal Investigators, CLSA Theme Leaders and other Key Co-investigators of CLSA, and/or to other national/international longitudinal studies of aging, including collaborative projects under the UK New Dynamics of Aging Programme.
- One copy of all published research articles resulting from this Fellowship must be forwarded to the CIHR Institute of Aging.
- Given that awardees will be contributing to the knowledge base of the Canadian Longitudinal Study on Aging, they may be called upon by CLSA Principle Investigators or the CIHR Institute of Aging to participate in promotional activities, such as symposia, workshops and newsletters
- Additional support is possible through the Age+ Award.
Contact Information
- For questions about this initiative and research objectives contact:
Erica Dobson
Project Officer
CIHR - Institute of Aging
Telephone: 613-946-7656
Email: erica.dobson@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
2. Amyotrophic Lateral Sclerosis - Ronald Peter Griggs Memorial Fellowship in ALS Research (Updated: 2009-08-26)
Summary
- The Amyotrophic Lateral Sclerosis Society of Canada - ALS Canada in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below:
- Proteomics related to ALS
- Genomics related to ALS
- Motor neuron biology
- Motor neuron disease related to ALS
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years. The total amount available for this initiative is $165, 000. This amount may increase if additional funding partners decide to participate.
Additional Information
- The award must be held in Canada.
- The Institute of Neurosciences, Mental Health and Addiction (INMHA) has a partnership with ALS on this opportunity.
Contact Information
- For questions about this initiative and research objectives contact:
Barbara Beckett
Assistant Director
CIHR - INMHA
Telephone: 613-948-4877
Fax: 613-954-1800
Email: barbara.beckett@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
3. Clinical Research
Summary
- The CIHR Patient-Oriented Research Strategy will fund applications that are determined to be relevant to their research priority areas described below:
- This priority announcement is directed to licensed health professionals engaged in clinical research. Candidates must hold a valid Canadian license (full or educational) at the time of application. Canadian licensure must be maintained for the duration of the award.
- Clinical Research is that part of the continuum of health research which is conducted on humans or on materials, specimens, or data derived from humans and populations with a focus on:
- Mechanisms of human health and disease;
- Bench to bedside to bench research;
- Clinical Trials and observational studies of prevention and therapy; and
- Clinical Epidemiological studies.
- In addition, clinical research may utilize the methods of health care services/systems research and population health research as they relate to clinical encounters.
- More information on the research priorities of CIHR Patient-Oriented Research Strategy can be found on their website.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 5 years.
- The total amount available for this initiative is $600,000. This amount may increase if additional funding partners decide to participate. CIHR-Patient-Oriented Research Strategy anticipates that two awards will be offered through this competition.
Contact Information
- For questions about this initiative and research objectives contact:
Sue Geffken-Graham
Assistant Director
CIHR - Patient-Oriented Research Strategy
Telephone: 613-948-2803
Fax: 613-954-1800
Email: sue.geffken-graham@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
4. Collaborative Research Program
Summary
- CIHR through the CIHR/Rx&D Collaborative Research Program in partnership with Rx&D – Canada's Research-Based Pharmaceutical Companies, will fund clinical research which is relevant and of interest to Rx&D member companies.
- More information on the research priorities of Rx&D is available on their website.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 5 years.
- The total amount available for this initiative is $300,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- Candidates must have secured partnered funding (ratio 1:1, CIHR:Industry) from an Rx&D member company at the time that the application is submitted. A company is eligible provided that it:
- Is federally or provincially incorporated in Canada (exceptions will be considered upon receipt of documentation that a researcher has been unable to develop a collaboration with a suitable federally or provincially incorporated company in Canada);
- Demonstrates adequate resources to meet its commitment to a program; and
- Has a demonstrable ability to apply the results of research and development itself or through agreements with other companies having the capacity to produce and market products and processes.
Contact Information
- For questions about this initiative and research objectives contact:
Julie Calendino
Associate, Clinical Research Initiative
Canadian Institutes of Health Research
Telephone: 613-948-2564
Fax: 613-954-1800
Email: julie.calendino@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
5. Dystonia (Small Health Organizations Partnership Program)
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Dystonia Medical Research Foundation of Canada (DMRFC), will fund applications that are determined to be relevant to the research priority areas described below:
- Dystonia.
- Basal ganglia
- Deep Brain Stimulation
- Blepharospasm
- Neuroplasticity
- Major areas of dystonia research include the clinical characterization of dystonias, genetic and pathophysiologic studies striving to reveal their causes, as well as development of novel treatment and rehabilitation options. More specifically, key areas of current interest are:
- Neurosurgery (Deep Brain Stimulation) – its physiological basis and improvements in current technology;
- Rehabilitation strategies and techniques for all dystonias (eg., generalized, focal, secondary dystonia, etc.);
- Genetics – Identification of new genes and screening of families with dystonia inheritance patterns;
- Clinical Trials – Setting up clinical trials by selecting suitable patient groups and identification of existing and experimental drugs based on genetic and pathophysiologic discoveries.
- More information on the research priorities of the Dystonia Medical Research Foundation of Canada can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000.
Additional Information
- Award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
6. Fanconi Anemia (Small Health Organizations Partnership Program) [Added: 2009-08-12]
Summary:
- CIHR, through the Small Health Organizations Partnership Program (SHOPP), in partnership with Fanconi Canada, will fund applications that are determined to be relevant to the research priority area described below:
- More information on the research priorities of the Fanconi Canada can be found on their website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000.
Additional Information
- Award must be held in Canada.
Contact information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
7. Fragile X (Small Health Organizations Partnership Program)
Summary
- CIHR through the Small Health Organization Partnership Program (SHOPP), in partnership with the Fragile X Research Foundation of Canada (FXRFC), will fund applications that are determined to be relevant to the research priority areas described below:
- Synaptic plasticity
- mGluR receptors
- Map1b
- GSK3 Beta Inhibitors
- Psychopharmacology
- Nootropic agents
- Gene therapy
- Protein replacement therapy
- More information on the research priorities of Fragile X Research Foundation of Canada (FXRFC) can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $660,000.
Additional Information
- The award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
8. Hepatology Fellowship Program (CASL/CIHR)
Summary
- Basic and Clinical Research in Hepatology
- Scientific questions/problems related to hepatology eg.viral hepatitis
- Knowledge translation questions/problems on diseases affecting the liver
- The Canadian Association for the Study of the Liver (CASL) in association with Canadian Institutes of Health Research (CIHR) and our industrial partners (Astellas Pharma Canada Inc., Axcan Pharma, Schering Canada, Hoffmann-La Roche) have established fellowships to support clinical or basic research in hepatology in Canada.
- The purpose of this funding opportunity is to build, in collaboration with industry, Canadian capacity and expertise in the area of hepatology. It is expected that this targeted investment will promote excellence in research through training awards.
- In addition, the intent of this initiative is to facilitate the translational objectives of CIHR, with particular interests in clinical research. Clinical research combines discoveries from the basic science laboratory incorporating the observations and insights of health professionals (a key aspect of translational research). It is the creation of new health knowledge and the translation of that knowledge from the research setting into applications where it ultimately impacts on the health of Canadians.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 2 years.
- The total amount available for this initiative is $240,000. This amount may increase if additional funding partners decide to participate.
Additional Requirements
- Eligibility requirements specific to this funding opportunity include the following:
- Candidates must hold either an MD or PhD degree; however, MD's will be given priority.
- MD candidates must have completed their primary specialty (e.g. General Internal Medicine or Pediatrics) and preference will be given to those who have also completed a Gastroenterology residency by the time the fellowship is to start.
- Both Canadians and non-Canadians can apply, but non-Canadians will only be considered if there are no Canadians eligible for the award.
- In addition to CIHR standard guidelines and requirements, the following special requirements shall apply:
- The award must be initiated within a maximum two (2) years following completion of the candidate's specialty or subspecialty training. During the tenure of the fellowship, fellows are not permitted to hold a second major award. In general, it is recommended that these Fellowships be carried out at Canadian centres unless it can be shown that no equivalent training is available in Canada. For training in Canada, the supervisor has to be a member of the Canadian Association for the Study of the Liver.
- Partner/Collaborator Description
- Canadian Institutes of Health Research (CIHR)
- CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system
- Canada's Research-Based Pharmaceutical Companies (Rx&D)
- (Rx&D) is an association of members dedicated to improving the health of all Canadians. As a partner in the health-care system, our discoveries help eliminate the need for medical procedures such as surgery, which have a significant impact on patient quality of life and health-care budgets. Our community represents over 20,000 men and women working for more than 50 member companies in Canada and is responsible for generating 100,000 jobs across Canada.
- The CIHR/Rx&D Collaborative Research Program is inspired by the longstanding successful collaboration between the pharmaceutical research industry and CIHR. Under this program, the eligible company partner is a member of Canada's Research-Based Pharmaceutical Companies (Rx&D). The Program promotes peer-reviewed research and enhances the training and development of health research personnel and opportunities in Canada. The Program is designed to enable scientists, clinicians and members of the full spectrum of health professionals, and Rx&D members to optimize their access to the unique opportunities and advantages offered by CIHR's translational research opportunities, including clinical research.
- Canadian Association for the Study of the Liver (CASL)
- The Canadian Association for the Study of the Liver represents a multidisciplinary group of doctors, scientists and health care providers whose expertise focuses on the liver. CASL is committed to providing national leadership in all aspects of research, teaching and patient care as it pertains to the liver. Our goals are to improve the quality of health care; support education; promote research and provide a forum for research dialogue; and enhance our role as a world leader in hepatology. These goals are achieved by developing partnerships with groups including research agencies, charitable organizations, universities, governments, industry, regulatory bodies, allied health care workers, and the public
Contact Information
- For questions about this initiative and research objectives contact:
Julie Calendino
Associate, Clinical Research Initiative
Canadian Institutes of Health Research
Telephone: 613-948-2564
Fax: 613-954-1800
Email: julie.calendino@cihr-irsc.gc.ca
or
- Dr. Robert P. Myers
Chair, Education Committee
Canadian Association for Study of Liver (CASL)
34 Eglinton Avenue West, Suite 323
Toronto, ON M4R 2H6
Tel: 416-847-0053
Fax: 416-847-0054
Email: casl@hepatology.ca
9. HIV/AIDS
Summary
- The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below (the primary research focus must be HIV/AIDS).
- Health systems, services and policy
- Resilience, vulnerability and determinants of health
- Prevention technologies and interventions
- Drug development, toxicities and resistance
- Pathogenesis
- Issues of co-infection and co-morbidity
- Note: Applicants must select only ONE priority area
- More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic is encouraged.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to five years. CIHR anticipates that approximately four awards will be funded through this competition.
Additional Requirements
- Applications to the HIV/AIDS Research Initiative are sought in two distinct funding streams - Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach across all four research pillars are strongly encouraged and accepted, applicants must clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
Contact Information
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Program Officer
CIHR - HIV/AIDS Research Initiative
Telephone: 613-941-4464
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
10. Huntington's Disease
Summary
- The Huntington Society of Canada (HSC) in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority area described below.
- Basic biomedical research in the area of Huntington's disease.
- More information on the Huntington Society of Canada can be found on their website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- The award winner will be the highest-ranked eligible candidate from the October 2009 and February 2010 open Fellowship competitions.
- The award must be held in Canada.
- Trainees must propose a research training program in Canada to be eligible for this award. (Awards only.)
- Only one trainee per lab will be eligible to receive funding. (Awards only)
- Recipient will be the top ranked researcher.
Contact Information
- For questions about this initiative and research objectives contact:
Barbara Beckett
Assistant Director
CIHR-INMHA
Telephone: 613-948-4877
Fax: 613-954-1800
Email: barbara.beckett@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
11. Hypertension (Small Health Organizations Partnership Program)
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Canadian Hypertension Society, will fund applications that are determined to be relevant to the research priority areas described below:
- Hypertension
- Vascular Biology
- Kidney function as it pertains to blood pressure
- More information on the research priorities of Canadian Hypertension Society can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000.
Additional Information
- The award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
12. Incontinence (Small Health Organizations Partnership Program)
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Canadian Foundation for Research on Incontinence (CFRI), will fund applications that are determined to be relevant to the research priority areas described below:
- More information on the research priorities of the Canadian Foundation for Research on Incontinence can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 2 years.
- The total amount available for this initiative is $110,000.
Additional Information
- The award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai,
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
13. Inflammatory Bowel Disease
Summary
- Institute of Nutrition Metabolism and Diabetes in partnership with the Canadian Association of Gastroenterology, Abbott, Axcan, Crohn's and Colitis Foundation of Canada, Ferring, CIHR Institute of Infection and Immunity and the CHIR Rx&D Collaborative Research Program
- Research Priority Areas:
- Basic or clinical research related to gastroenterology/nutrition
Funds Available
- The maximum amount awarded for a single award is up to $50,000 per annum for Ph.D.'s, and $60,000 for M.D.'s, for up to 2 years. This includes an annual research allowance of $5,000, and an out-of-country supplement of $5,000 per annum which will be paid in addition to the regular award should the Fellowship be held outside Canada.
- The total amount available for this initiative is $840,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- Relevancy Review Criteria:
- Relevance to, or aligment of, the research proposed to Inflammatory Bowel Disease (IBD)
- Relevant to building Canadian research capacity in the field of Inflammatory Bowel Disease (IBD)
- The post-doctoral fellow must be a medical graduate registered in a fellowship program in Canada or have completed a PhD degree and be engaged in post-doctoral research related to gastroenterology or nutrition.
- Medical graduates must have completed clinical residency training in a recognized adult or pediatric training program (inside or outside of Canada) to the extent that they are eligible (or equivalent) to write Royal College certification exams at the time of starting the award.
- The post-doctoral fellow need not be a Canadian Citizen or Landed Immigrant, but preference will be given to candidates whose academic careers will strengthen Canadian gastroenterology. Fellowships sponsored by partners other than AstraZeneca are normally tenable only at a Canadian university, hospital, or research institute. However, the Fellowship may be tenable outside of Canada if the applicant is to receive training which, in terms of its nature and/or quality, could not be obtained in Canada, and if there is reasonable assurance that the applicant will be returning to an academic position in Canada.
- The post-doctoral fellow must focus all of their research activities on the research program outlined in the application and this must represent at least 80% of their time.
- Nominated Principal Applicants must register and become CAG members.
- The supervisor must be a CAG Regular Member in good standing at time of application.
- It is a requirement of the awards that all papers and abstracts submitted for publication of work resulting from this program must be sent concurrently to the Industry Partner and include (in the case of papers) acknowledgement of the Award. The Industry partner will not delay or influence publication in any manner.
- Randomized clinical trials are not eligible under this funding opportunity.
Contact Information
- For questions about this initiative and research objectives contact:
Paul Sinclair
Executive Director
Canadian Association of Gastroenterology
224-1540 Cornwall Road
Oakville, ON L6J 7W5
Telephone: 905-829-2504
Toll-free: 1-888-780-0007
Fax: 905-829-0242
Email: cagoffice@cag-acg.org
Paul Bélanger
Assistant Director
CIHR - Institute of Nutrition Metabolism and Diabetes
Telephone: 613-941-6465
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
14. Knowledge Translation
Summary
- CIHR will fund applications that are determined to be relevant to the research priority areas described below:
- The Science and Practice of knowledge translation (KT)
- CIHR's mandate is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. The purpose of this funding opportunity is to further strengthen knowledge translation (synthesis, dissemination, exchange and ethically sound application of knowledge) by supporting knowledge translation trainees early in their careers. It is expected that this targeted investment will lead to a better understanding of concepts, theories and practices that underlie effective KT in order to improve the health of Canadians, provide more effective health services and products and strengthen the health care system.
- More information on the research priorities of the CIHR Knowledge Translation Portfolio can be found on their website.
Funds Available
- The maximum amount awarded for a single award is $60,000 per annum for up to three years. CIHR anticipates that a minimum of one award will be offered through this competition.
- The total amount available for this initiative is $180,000. This amount may increase if additional funding partners decide to participate.
Contact Information
- For questions about this initiative and research objectives contact:
Alison Lott
Senior KSE Specialist
CIHR - Knowledge Synthesis and Exchange Branch
Telephone 613-948-2682
Facsimile 613-954-1800
Email: alison.lott@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
15. Lysosomal Storage Disorders (Small Health Organizations Partnership Program).
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Canadian Society for Mucopolysaccharide and Related Diseases will fund applications that are determined to be relevant to the research priority areas described below:
- Lysosomal storage disorders
- More information on the research priorities of the Canadian Society for Mucopolysaccharide and Related Diseases can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000. It is anticipated that one award will be funded through this competition.
Additional Information
- Award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
16. Medical Oncology CAMO/CIHR Rx&D Research
Summary
- The objective of this initiative is to provide an opportunity for individuals who have completed their Medical Oncology training in Canada to have additional clinical and/or fundamental (basic) research experience. It is expected that this targeted investment will build Canadian capacity and expertise in the area of oncology and will promote excellence in research through training awards.
- The field of medical oncology is rapidly changing, with the introduction of new drugs and biologics with an emphasis on targeted therapies, predictive and prognostic markers and translation of new therapies into practice. Medical oncologists wishing to pursue an academic career require further training in basic and clinical research; often completing a graduate degree in the process. The CIHR/CAMO Fellowship Program provides funding for excellent candidates with projects designed to ensure higher levels of training.
- In addition, the intent of this initiative is to facilitate the translational objectives of CIHR, with particular interests in clinical research. Clinical research combines discoveries from the basic science laboratory incorporating the observations and insights of health professionals (a key aspect of translational research). It is the creation of new health knowledge and the translation of that knowledge from the research setting into applications where it ultimately impacts on the health of Canadians.
- The specific objectives of this funding opportunity are:
- To address scientific questions/problems related to basic science, clinical or translational research questions in medical oncology, such as new drug development, genetic basis of cancer, and prognostic and predictive markers of outcome.
- To address knowledge translation questions/problems related to integration of new therapies in clinical practice, such as population health related to cancer including treatment and quality indicators of cancer system performance.
- To develop the capacity in Canada to actively participate in these research areas by providing further training opportunities for medical oncologists completing training in Canada.
- Relevant Research Areas
- Basic lab research and its translation into clinical approaches
- Clinical trials and epidemiology
- Educational research
- Population health
Funds Available (Updated: 2009-07-31)
- The maximum amount awarded for a single award is up to $75,000 per annum for up to 2 years.
- The total amount available for this initiative is $450,000. This amount may increase if additional funding partners decide to participate.
- Trainee stipend: $65,000 per annum.
- Research allowance: $5,000 per annum.
- For awards held outside Canada, $5,000 is added to the annual stipend.
Additional Information
- Eligibility requirements specific to this funding opportunity include the following:
- Candidates must be Canadian citizens or landed immigrants.
- The candidate must hold a degree in Medicine, an FRCPC in Internal Medicine, be in their final year of training in a Royal College certified training program for Medical Oncology and be an associate member of CAMO. CAMO will give consideration to applications on a competitive basis from individuals in the first year of a fellowship training program who wish to extend their training up to one-year. Priority for funding, however, will be given to first-year applicants.
- Review Process and Evaluation
- CAMO and CIHR will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described in the "Objectives" section.
- Prior to peer review, the CAMO will have access to anonymized project titles and summaries to conduct relevance review.
- Upon completion of peer review, the CAMO will receive the ranking list, merit scores (ratings) and recommendations on funding level and award term for the applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative. The list will be used for funding decision-making purposes and will remain anonymous
Contact Information
- For questions about this initiative and research objectives contact:
- Julie Calendino
Associate, Clinical Research Initiative
Canadian Institutes of Health Research
Telephone: 613-948-2564
Fax: 613-954-1800
Email: julie.calendino@cihr-irsc.gc.ca
- Or
Aaron Jackson
Team Lead, Program Delivery
Canadian Institutes of Health Research
Telephone: 613-957-1188
Fax: 613-954-1800
Email: aaron.jackson@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
17. Primary Health Care
Summary
- Across Canada there has been significant innovation and experimentation with primary care reform, including team-based approaches and alternative funding and delivery models. Nonetheless Canada's primary care sector lags behind other countries with similar wealth and health systems, most notably in after-hours care, wait times, chronic disease management, mental health, quality improvement and electronic medical records (Schoen 2006, 2007, Starfield 2005, 2008). Existing evidence on the impact of various approaches to how primary care is structured and delivered needs to be synthesized and best practices identified. As well, we need better evidence on how to achieve high-quality, comprehensive and coordinated primary care (including coordination with other parts of the system) that results in improved health outcomes. This requires a focus on holistic patient-centred care, governance, funding and managerial structures, access and delivery methods, integration, performance measurement, continuous quality improvement, technology and change management. Research is needed that looks for practical solutions, moving theory into practice and promoting the scaling up of innovation across the country.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 3 years. The total amount available for this initiative is $540,000. This amount may increase if additional funding partners decide to participate. It is anticipated that 3 awards will be funded through this competition.
Contact Information
- For questions about this initiative and research objectives contact:
Christian Brochu
Associate Strategic Initiatives
CIHR – Institute of Health Services and Policy Research (IHSPR)
Telephone: 613-952-4539
Email: christian.brochu@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
18. Pulmonary Arterial Hypertension (CIHR/CLA/GSK) [Added: 2009-09-01]
Summary:
- The specific objective of this funding opportunity is to encourage a broad spectrum of post-doctoral fellows (PhD and MD) to train in the field of Pulmonary Arterial Hypertension as specified below:.
- Basic resesarch in Pulmonary Arterial Hypertension
- Clinical research in Pulmonary Arterial Hypertension
- Health Services/health systems in Pulmonary Arterial Hypertension
- Population health in Pulmonary Arterial Hypertension
- Training projects in Pulmonary Arterial Hpertension
- In addition, the intent of this initiative is to facilitate the translational objectives of CIHR, with particular interests in clinical research. Clinical research combines discoveries from the basic science laboratory incorporating the observations and insights of health professionals (a key aspect of translational research). It is the creation of new health knowledge and the translation of that knowledge from the research setting into applications where it ultimately impacts on the health of Canadians.
- More information on the research priorities of the Canadian Lung Association (CLA) and GlaxoSmithKline (GSK) can be found on their web sites.
Funds Available:
- The maximum amount awarded for a single grant is up to $ 60,000 per annum for up to 2 years.
- The total amount available for this initiative is $ 120,000. This amount may increase if additional funding partners decide to participate.
Additional Information:
- The award is non-renewable.
- Only one trainee per lab will be eligible to receive funding.
Contact Information:
- For questions about this initiative and research objectives contact:
Julie Calendino
Associate, Clinical Research Initiative
Canadian Institutes of Health Research
Telephone: 613-948-2564
Fax: 613-954-1800
E-mail: julie.calendino@cihr-irsc.gc.ca
or
Anne Van Dam
Manager, National Research Programs
The Lung Association - National Office
Telephone: 613-569-6411 ext 222
Fax: 613-569-8860
Email: avandam@lung.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
19. Regional Partnerships Program
Contact Information
- Specific contact information for each province can be found in the descriptions below.
- For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Lisa Rivet
Program Delivery Coordinator, Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-948-2517
Fax: 613-954-1800
Email: lisa.rivet@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
19a. Regional Partnerships Program - Manitoba
Summary
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- The award must be held in Manitoba.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements.
- Funding is conditional upon the availability of funds.
- Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their award to be eligible for consideration for RPP funding.
- When applying through ResearchNet, please ensure to select RPP-Manitoba in the drop-down menu of the priority announcement.
Contact Information
- For additional information on eligibility criteria and funding details, please contact:
Shannon Rogalski
Manager, Funding Programs
Manitoba Health Research Council
Phone: 204-783-4249
Email: shannon.rogalski@mhrc.mb.ca
19b. Regional Partnerships Program – New Brunswick
Summary
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to five years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- The award must be held in New Brunswick.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements.
- Funding is conditional upon the availability of funds.
- For eligibility guidelines, see the New Brunswick – CIHR RPP program description.
- When applying through ResearchNet, please ensure to select RPP-New Brunswick in the drop-down menu of the priority announcement.
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding.
Contact Information
- For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne
Administrator, Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB, E3B 5G8
Telephone: 506 444-3222
Fax: 506 453-2958
Email: john.boyne@gnb.ca
19c. Regional Partnerships Program – Newfoundland and Labrador
Summary
- CIHR, through the Regional Partnerships Program (RPP) in partnership with Newfoundland and Labrador - RPP is interested in funding applications in all four themes of health research in Newfoundland and Labrador.
- More information on the research priorities of Newfoundland and Labrador can be found on their website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- Trainees must propose a research training program in Newfoundland and Labrador to be eligible for this award;
- Only one trainee will be eligible to receive funding with a single Principle Investigator;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds;
- When applying through ResearchNet, please ensure to select RPP-Newfoundland and Labrador in the drop-down menu of the priority announcement.
- Please note that researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP- Newfoundland and Labrador in order for their grant to be eligible for consideration for RPP funding.
Contact Information
- Office of Research and Graduate Studies
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL, A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
19d. Regional Partnerships Program – Prince Edward Island
Summary
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island - RPP is interested in funding applications that span the four themes of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect the four themes:
- Cardiovascular and respiratory health research
- Metabolism, Nutrition and Diabetes
- Human Development and Cognition
- Cancer Research
- Applied Health Services and Health Promotion
- Natural products and Human health
- Population Health
- More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- Only one trainee per lab will be eligible to receive funding;
- The award must be held in Prince Edward Island;
- Trainees must propose a research training program in Prince Edward Island to be eligible for this award;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds;
- When applying through ResearchNet, please ensure to select RPP-Prince Edward Island in the drop-down menu of the priority announcement.
- For eligibility guidelines, see the PEI-CIHR RPP program description.
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the Office of Research Development a minimum of one month prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Leslie Cudmore
University of Prince Edward Island
Office of Research & Development
550 University Avenue
Charlottetown, PE, C1A 4P3
Telephone: 902-566-0709
Fax: 902-620-5092
Email: lcudmore@upei.ca
19e. Regional Partnerships Program - Saskatchewan
Summary
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan - RPP is interested in funding highly rated applications in Saskatchewan in all four themes of research.
- Fellowships awarded to health professionals for the purpose of doctoral training will be funded for up to three years. Post-doctoral fellows (PDFs) will be funded for up to two years. PDFs who have already received a 2-year award from the Saskatchewan Health Research Foundation (SHRF) Research Fellowship Program will only be supported for one year.
- The awarded funding will be established at the appropriate minimum amounts set by CIHR regulations. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- An award is usually made for one year with a requirement to re-apply to CIHR. Renewal is automatic if the re-application is considered fundable by CIHR (i.e. 3.5 or greater rating). Otherwise the awards are not renewable.
- For additional information on eligibility criteria and funding details, please refer to Saskatchewan-CIHR RPP Policies.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
Additional Information
- The award must be held in Saskatchewan, but the project can involve some work outside the province;
- All Fellows must be under the supervision of an investigator holding an appointment at a university in Saskatchewan;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- Funding is conditional upon the availability of funds.
- When applying through ResearchNet, please ensure to select RPP-Saskatchewan in the drop-down menu of the priority announcement.
20. Respiratory Health CIHR/CLA/GSK
Summary
- The purpose of this funding opportunity is to build Canadian capacity and expertise in the area of respiratory health and to promote excellence in research through training awards. The priority for this fellowship competition will focus upon the study of airflow obstruction and the associated diseases of airflow obstruction. This funding will be aimed at improving Canadian research into the pathophysiology, cell biology, population health and health systems research focused upon diseases such as asthma and COPD.
- The specific objective of this funding opportunity is to encourage a broad spectrum of post-doctoral fellows (PhD and MD) to train in the field of respiratory health. Canada has traditionally been a world leader in research into asthma and COPD. We anticipate that this funding will help maintain research excellence in these areas of study.
- In addition, the intent of this initiative is to facilitate the translational objectives of CIHR, with particular interests in clinical research. Clinical research combines discoveries from the basic science laboratory incorporating the observations and insights of health professionals (a key aspect of translational research). It is the creation of new health knowledge and the translation of that knowledge from the research setting into applications where it ultimately impacts on the health of Canadians.
- Relevant Research Areas
- Training projects in respiratory health research, across four broad research themes: basic, clinical, health services/health systems, and population health. These awards will be focused to maintain and improve Canadian research capacity.
- Examples of research that might be conducted under this funding opportunity are provided below. These examples are not intended to be exhaustive and there is no intent to imply that applications in these research areas would be more successful than those in other research areas.
- functional genomics
- cell biology
- physiology and structure/function integration
- clinical trials
- clinical epidemiology
- health service utilization.
Funds Available
- The maximum amount awarded for a single award is up to $60,000 per annum for up to 2 years. The total amount available for this initiative is $240,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- Review Process and Evaluation
- Relevance Review
- CIHR, CLA, CTS and GSK will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described in the "Objectives" section.
- Prior to peer review, the CLA and GSK will have access to anonymized project titles and summaries to conduct relevance review.
- The following criteria will be used in conducting the relevance review:
- Fit with the Program goals.
- Response to relevant research areas.
- Upon completion of peer review, the CLA and GSK will receive the ranking list, merit scores (ratings) and recommendations on funding level and award term for the applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative. The list will be used for funding decision-making purposes and will remain anonymous.
Contact Information
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
21. Thalassemia (Small Health Organization Partnership Program)
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Thalassemia Foundation of Canada, will fund applications that are determined to be relevant to the research priority areas described below:
- Thalassemia: Cardiovascular and respiratory health
- Thalassemia: Metabolism
- Thalassemia: Blood
- Thalassemia: Iron overload
- More information on the research priorities of the Thalassemia Foundation of Canada can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 2 years.
- The total amount available for this initiative is $110,000.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR – Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
22. Transfusion Science
Summary
Funds Available
- The maximum/minimum amount awarded for a single award is up to $55,000 per annum for up to 3 years (Updated: 2009-07-17) . The total amount available for this initiative is $550,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- The award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Jennifer Ralph (Updated: 2009-09-23)
Project Manager
CIHR – Institute of Circulatory and Respiratory Health
Telephone: 613-941-0086
Email: jennifer.ralph@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
23. Women's health (Small Health Organization Partnership Program)
Summary
- CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Canadian Foundation for Women's Health will fund applications that are determined to be relevant to the research priority areas described below:
- Maternal Fetal Medicine
- Gynecologic Oncology
- Fertility
- Medical Education
- Pre-invasive Gynecologic cancer
- Paediatric and Adolescent Gynecology
- Menopause
- Contraception
- Pelvic Floor
- More information on the research priorities of the Canadian Foundation for Women's Health can be found on their Website.
Funds Available
- The maximum amount awarded for a single award is up to $55,000 per annum for up to 3 years.
- The total amount available for this initiative is $165,000.
Additional Information
- The award must be held in Canada.
Contact Information
- For questions about this initiative and research objectives contact:
Mary Beshai
Senior Advisor
CIHR - Partnerships
Telephone: 613-957-4160
Fax: 613-954-1800
Email: mary.beshai@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
B. Prizes in CIHR Research Priority Areas
24. Aging - CIHR Institute of Aging Fellowship Recognition Prize in Research on Aging
Summary
- The CIHR Institute of Aging (CIHR-IA) aims to advance knowledge in the field of aging to improve the quality of life and the health of older Canadians. With this goal in mind, CIHR-IA has been investing in the future of research on aging by developing and supporting capacity-building research initiatives and programs to train support new and emerging researchers in the field of aging.
- The CIHR-IA Fellowship Recognition Prize in Research on Aging encourages and honours our brightest rising stars. It consists of a supplement to the research allowance valued at a maximum of $5,000 in year one of the Fellowship award. No additional application is needed.
Funds Available
- The maximum amount awarded for a single prize is up to $5,000 per annum for up to 1 year. One prize will be offered.
Additional Information
- The recipient of the prize will be the candidate conducting research relevant to CIHR-IA's Priority topics who has received the highest rating through the October 2009 and the February 2010 CIHR Fellowship competitions.
Contact Information
- For questions about this initiative and research objectives contact:
Sharon Nadeau
Associate
CIHR-IA – Strategic Initiatives
Telephone: 613-946-1270
Fax: 613-954-1800
Email: sharon.nadeau@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
25. Bisby (Prize)
Summary
- Bisby Fellowship. Dr. Mark Bisby joined the former Medical Research Council of Canada in 1997 as Director of the Programs Branch. From his arrival in 1997 to his retirement in June 2006, he played an important liaison role with Canada's research community, firstly in ensuring that there was a smooth transition between MRC and CIHR and then creating an environment of research excellence to cultivate the broadened research mandate of CIHR. In honouring Dr. Bisby's commitment to CIHR and the health research community, CIHR offers Fellowship Awards in his name.
- An award will be offered to the highest ranking candidates in each of the Fellowship committees in each CIHR Fellowship competition. In addition to receiving the applicable stipend and a research allowance under the fellowship program, awardees will carry the distinction of being branded a Bisby Fellow and will receive a supplement to the research allowance of an additional $5,000. The intent of the additional research allowance is to enable recipients to assert themselves as thought leaders on the national and international research stage through engagement in national or international conferences, workshops or meetings related to the award recipient's research.
Funds Available
- The maximum amount awarded for a single award is up to $5,000 per annum for up to 5 years. The total amount available for this initiative is $125,000. This amount may increase if additional funding partners decide to participate.
Additional Information
- Recipient will be the top ranked researcher.
Contact Information
- For questions about this initiative and research objectives contact:
Christina Disipio
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-952-9873
Fax: 613-954-1800
Email: christina.disipio@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
26. Cancer (Prize)
Summary
- Jean-François St-Denis, PhD (August 14, 1966 - March 2, 2004) joined the Canadian Institutes of Health Research (CIHR) in 2000, after completing a PhD at the University of Montreal and postdoctoral studies at the National Institutes of Health in Bethesda, Maryland and the Hospital for Sick Children in Toronto. CIHR is pleased to honour Dr. St-Denis' courageous struggle against cancer by offering a Fellowship Award in his name. This award is offered to an outstanding individual who is to undertake postdoctoral training in the field of cancer research.
- One award will be offered to the highest ranking candidate who applies to one of the two Fellowship Award competitions each year (October and February), whose research focus is on cancer and who is ranked highly enough to be approved for a regular CIHR Fellowship Award. The CIHR Jean-François St-Denis Fellowship consists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to cancer research.
Funds Available
- The total amount available for this initiative is $25,000. This amount may increase if additional funding partners decide to participate. The maximum amount awarded for a single award is up to $5,000 per annum for up to 5 years.
Additional Information
- Recipient will be the top ranked researcher.
- The recipient of the award will be the top ranked application in the field of cancer research as identified through the results of the October 2009 (200910MFE) and February 2010 (201002MFE) competitions for the 2009-2010 CIHR Fellowship program
Contact Information
- For questions about this initiative and research objectives contact:
Christina Disipio
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-952-9873
Fax: 613-954-1800
Email: christina.disipio@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
27. Knowledge Translation - Elizabeth Dickson KT Fellowship Supplement
Summary
- This award supplement is offered to an outstanding individual who is to undertake postdoctoral or post health professional training in the field of Knowledge Translation.
- A supplement will be offered to the highest ranked and funded candidate from the Fall 2009 Fellowship Award competition who has applied to, and been deemed relevant for, the Knowledge Translation Priority Announcement. The Elizabeth Dickson KT Fellowship Supplement consists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to the award recipient's research.
- Dr. Elizabeth Dickson played a key role in the launch of the CIHR in the year 2000, leading efforts to meet critical milestones in the mandated transformation. For more information on this prize, see the Knowledge Translation web site.
- The maximum amount awarded for a single award supplement is up to $5,000 for one year. CIHR anticipates that one supplement will be offered through this competition.
- In addition to the standard KT activities of presenting research findings to targeted audiences and producing lay summaries for dissemination, recipients of the KT award supplement are expected to undertake one of the following activities:
- Present at a CIHR summer institute, CIHR lunch and learn session, or KT trainee network event;
- Create a short podcast for posting on the CIHR website; or
- Carry out a clearly defined activity to be proposed to and approved by the Knowledge Synthesis and Exchange Branch.
- Associated costs will be covered by CIHR and activities will be undertaken in coordination with the Knowledge Synthesis and Exchange Branch.
Funds Available
- The maximum/minimum amount awarded for a single award supplement is up to $5000 per annum for up to 1 year. The total amount available for this initiative is $5000. This amount may increase if additional funding partners decide to participate.
Contact Information
- For questions about this initiative and research objectives contact:
Alison Lott
Senior KSE Specialist
Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-948-2682
Fax: 613-954-1800
Email: alison.lott@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
28. Schizophrenia (Prize)
Summary
- In 1993, Dr. Michael Smith received the Nobel Prize for Chemistry in 1993 for his discovery and development of a crucial technique known as site-directed mutagenesis, used in genetic engineering. His discovery enabled researchers to gain enormous insights into the structure and function of genes and proteins. Throughout his career, Dr. Smith strongly encouraged young people to pursue science as a career, and he has used his prize to promote science, encourage women to pursue interests in science and support research on severe mental illnesses, especially schizophrenia. To honor Dr. Smith's scientific accomplishments and his lifelong promotion of science, CIHR offers a Doctoral Research Award in his name (CIHR Michael Smith Fellowship Award for Research in Schizophrenia).
- To be considered eligible for this award, the application must be relevant to the research priority areas described below:
- Genetics, molecular genetics, imaging and biochemistry of the central nervous system with application to schizophrenia.
Additional Requirements
- Recipient will be the top ranked researcher.
- One award will be offered through this competition.
- The recipient of the award will be the top ranked schizophrenia researcher as identified through the results of the October 2009 (200910MFE) competition of the 2009-2010 CIHR Fellowship program.
Contact Information
- For questions about this initiative and research objectives contact:
Christina Disipio
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-952-9873
Fax: 613-954-1800
Email: christina.dispio@cihr-irsc.gc.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
Top
Eligibility
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Specific to CIHR training awards, please refer to the General Guidelines for Training Programs, as well as the Fellowship: 2009-2010 funding opportunity.
Top
Guidelines
General CIHR Guidelines
This funding opportunity will follow the General Guidelines for Training Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications.
Allowable Costs
The awards consist of a stipend and a research allowance.
For the research allowance, awardees should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.
Conditions of Funding
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Funding opportunity. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official languages policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Funding opportunity and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.
CIHR Guidelines for Health Research Involving Aboriginal People
The CIHR Guidelines for Health Research Involving Aboriginal People came into effect as policy for CIHR-funded research on July 1, 2008. Applicants whose proposed research will involve Aboriginal People are strongly encouraged to familiarise themselves with these guidelines and in particular with the section "Application of the Guidelines," which outlines the situations in which these guidelines apply.
Communication Requirements
Award recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes/partners will be identified on the Authorization for Funding and decision letter.
Top
Performance Measurement
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
- contribute to the monitoring, review and evaluation of CIHR's programs, policies and processes by participating in evaluation studies, surveys, workshops, audits and providing data or reports as required for the purpose of collecting information to assess progress and results;
- encourage their associates, trainees and administration to participate in the monitoring, review and evaluation of CIHR's programs, policies and processes as required.
Top
Review Process and Evaluation
Relevance Review
A. CIHR Research Priority Areas:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the Objectives section.
Relevance of the applications to the research priorities will be determined in the following manner.
Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority areas described above.
To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application.
Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded.
Applications deemed relevant to a priority announcement, which are funded in the regular Fellowship competition or through a priority announcement will be named "Fellowship in the area of [specific research area] research" (e.g., Fellowship in the area of aging research).
Peer review committees will not be informed of applications submitted for funding through this announcement.
B. Prizes in CIHR Research Priority Areas:
Upon completion of peer review, representatives of CIHR and/or partner organizations will receive an anonymized ranking list, funding level and peer review committee recommendations on award term for all applications 1) that are funded in the regular CIHR Fellowship competitions; and 2) that are identified as relevant through a keyword search. This information will be used to conduct relevance review when required and to determine the recipients of the prizes. These applications will be selected from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below the regular CIHR Fellowship competition cut-off will not be considered for prizes.
Peer review committees will not be informed of applications submitted for funding through this announcement.
Peer Review
A CIHR peer review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this funding opportunity. Committee members are selected based on suggestions from many sources including the institutes / portfolios and partners, following CIHR's Policy on Conflict of Interest and Confidentiality in the context of Merit, Relevance and Peer Review (CCIP). For information on CIHR's peer review process in general, see the Understand Peer Review section of CIHR's website.
Evaluation Criteria
Fellowship Awards are reviewed in accordance with the Guide for Reviewers – CIHR Fellowships.
The following general criteria for evaluating training award applications will be used:
- Achievements and Activities of the Candidate
- Characteristics and Abilities of the Candidate
- Research Training Environment
Top
How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
- The application process for this funding opportunity is comprised of one step: Application.
- The Application is submitted through the "200910MFE" competition of the Fellowship Award: 2009-2010 funding opportunity.
- To complete your Application, review the Fellowship: 2009-2010 funding opportunity and then follow the specific application guidelines and instructions which are fully described in its "How to Apply" section.
- An overview of CIHR's application processes can be found under Apply for Funding.
- Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.
Additional instructions that must be followed for this funding opportunity:
(Note: These additional instructions supersede all other policies or guidelines published by the Canadian Institutes of Health Research, including, but not limited to, the Grants and Awards Guide, the Memorandum of Understanding, etc.)
A. CIHR Research Priority Areas
- Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas".
- To apply for funding through these priority announcements, select the priority announcement title and relevant research areas addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
- You may request that your application be considered for up to three priority announcement research areas per application, in each Fellowship competition.
B. Prizes in CIHR Research Priority Areas:
- Priority Announcement prizes are listed in the "Objectives" section of this funding opportunity.
- Your application will automatically be entered into Priority Announcement prize competitions. Refer to the "Review Process and Evaluation Criteria" section above for further details. Consideration for funding through priority announcements prizes is in addition to consideration for priority announcement funding in specific research priority areas.
Top
Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Fellowships Program Delivery Coordinator
Research Capacity Development
Canadian Institutes of Health Research
Email: fellowships@cihr-irsc.gc.ca
Top
|
